Search results
Eli Lilly & Co (NYSE:LLY): Jim Cramer’s Best Weight Loss Stock Pick for 2024
Insider Monkey via Yahoo Finance UK· 4 days agoWe recently published a list of the 10 Stocks to Buy and Sell Before the Third Quarter 2024...
Pharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Zacks via Yahoo Finance UK· 8 hours agoEli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi...
FDA approves second Alzheimer’s drug that can modestly slow disease
Express and Star· 2 days agoThe Food and Drug Administration (FDA) approved Eli Lilly’s Kisunla, known chemically as donanemab,...
FDA approves Eli Lilly's treatment which slows symptoms down
Daily Mail· 3 days agoThe US FDA has approved donanemab, a treatment for Alzheimer's disease that helps the body remove...
A New Alzheimer’s Drug May Be the Most Effective One Yet
Time via Yahoo News UK· 2 days agoDonanemab, or Kisunla, is the third drug approved to target one of the causes of Alzheimer’s: the...
Lilly follows Biogen-Eisai in securing US FDA approval for Alzheimer's drug
Reuters· 2 days agoEli Lilly's Kisunla secured standard approval from the U.S. Food and Drug Administration on Tuesday...
FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease | CNN
CNN.com· 3 days agoThe US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to...
Weight-loss drugs linked with lower risk of obesity-related cancers
Gulf News· 5 hours agoBlockbuster weight loss and diabetes drugs may lower patients' risk of developing some common types...
How Jeremy Hunt survived the breaking of the Blue Wall
The New Statesman· 6 hours ago“This is the Holy Grail,” one Lib Dem told me as we sat waiting for the count in Godalming and Ash....
NVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
Zacks via Yahoo Finance UK· 1 day agoA new study led by investigators of a Harvard-affiliated teaching hospital found that Novo Nordisk's...